News Conference News VIVA 2024 Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II L.A. McKeown November 06, 2024
News Conference News VIVA 2017 Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD L.A. McKeown September 18, 2017